PARP6
Protein mono-ADP-ribosyltransferase PARP6
Also known as: ARTD17, PARP6_HUMAN, pART17
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2NL67
- Gene
- PARP6
- Ensembl
- ENSG00000137817
- Chromosome
- 15
- Canonical length
- 630 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Enables NAD+-protein-aspartate ADP-ribosyltransferase activity and NAD+-protein-cysteine ADP-ribosyltransferase activity. Involved in protein auto-ADP-ribosylation. Predicted to be active in endoplasmic reticulum tubular network and nuclear envelope. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
630 residues, UniProt reviewed canonical sequence.
>Q2NL67|PARP6
1 MDIKGQFWND DDSEGDNESE EFLYGVQGSC AADLYRHPQL DADIEAVKEI YSENSVSIRE
61 YGTIDDVDID LHINISFLDE EVSTAWKVLR TEPIVLRLRF SLSQYLDGPE PSIEVFQPSN
121 KEGFGLGLQL KKILGMFTSQ QWKHLSNDFL KTQQEKRHSW FKASGTIKKF RAGLSIFSPI
181 PKSPSFPIIQ DSMLKGKLGV PELRVGRLMN RSISCTMKNP KVEVFGYPPS PQAGLLCPQH
241 VGLPPPARTS PLVSGHCKNI PTLEYGFLVQ IMKYAEQRIP TLNEYCVVCD EQHVFQNGSM
301 LKPAVCTREL CVFSFYTLGV MSGAAEEVAT GAEVVDLLVA MCRAALESPR KSIIFEPYPS
361 VVDPTDPKTL AFNPKKKNYE RLQKALDSVM SIREMTQGSY LEIKKQMDKL DPLAHPLLQW
421 IISSNRSHIV KLPLSRLKFM HTSHQFLLLS SPPAKEARFR TAKKLYGSTF AFHGSHIENW
481 HSILRNGLVN ASYTKLQLHG AAYGKGIYLS PISSISFGYS GMGKGQHRMP SKDELVQRYN
541 RMNTIPQTRS IQSRFLQSRN LNCIALCEVI TSKDLQKHGN IWVCPVSDHV CTRFFFVYED
601 GQVGDANINT QDPKIQKEIM RVIGTQVYTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 68 nTPM
- cerebral cortex: 50 nTPM
- retina: 49 nTPM
- pituitary gland: 47 nTPM
- basal ganglia: 46 nTPM
- amygdala: 41 nTPM
Single-cell type
- late spermatids: 310 nCPM
- ependymal cells: 83 nCPM
- astrocytes: 80 nCPM
- bergmann glia: 73 nCPM
- sertoli cells: 69 nCPM
- oligodendrocytes: 65 nCPM
Immune cell
- eosinophil: 8.3 nTPM
- classical monocyte: 3.6 nTPM
- neutrophil: 3.6 nTPM
- non-classical monocyte: 3.5 nTPM
- intermediate monocyte: 3.1 nTPM
- NK-cell: 3 nTPM
Brain region
- cerebral cortex: 77 nTPM
- hippocampal formation: 72 nTPM
- white matter: 71 nTPM
- basal ganglia: 69 nTPM
- amygdala: 68 nTPM
- cerebellum: 67 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.18
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum unfolded protein response
- positive regulation of dendrite morphogenesis
- protein auto-ADP-ribosylation
Molecular functions
- kinase binding
- NAD+ poly-ADP-ribosyltransferase activity
- NAD+-protein-aspartate ADP-ribosyltransferase activity
- NAD+-protein-cysteine ADP-ribosyltransferase activity
- nucleotidyltransferase activity
- protein serine/threonine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARP6 as an antibody target. Whether an autoantibody or antibody against PARP6 could matter depends on whether native PARP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...